Logo image of SRBK

SR BANCORP INC (SRBK) Stock Fundamental Analysis

NASDAQ:SRBK - Nasdaq - US85227J1060 - Common Stock - Currency: USD

14.33  +0.02 (+0.14%)

After market: 14.33 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SRBK. SRBK was compared to 396 industry peers in the Banks industry. SRBK has a bad profitability rating. Also its financial health evaluation is rather negative. SRBK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year SRBK has reported negative net income.
In the past year SRBK had a positive cash flow from operations.
SRBK Yearly Net Income VS EBIT VS OCF VS FCFSRBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.01%, SRBK is doing worse than 91.16% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.05%, SRBK is doing worse than 91.16% of the companies in the same industry.
SRBK has a better Return On Invested Capital (1.37%) than 98.99% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRBK is below the industry average of 2.64%.
The last Return On Invested Capital (1.37%) for SRBK is above the 3 year average (0.46%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.01%
ROE -0.05%
ROIC 1.37%
ROA(3y)-0.18%
ROA(5y)N/A
ROE(3y)-0.86%
ROE(5y)N/A
ROIC(3y)0.46%
ROIC(5y)N/A
SRBK Yearly ROA, ROE, ROICSRBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -2 -4

1.3 Margins

SRBK has a better Operating Margin (41.16%) than 99.24% of its industry peers.
In the last couple of years the Operating Margin of SRBK has declined.
SRBK does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 41.16%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.83%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SRBK Yearly Profit, Operating, Gross MarginsSRBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 -20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRBK is destroying value.
The number of shares outstanding for SRBK has been increased compared to 1 year ago.
SRBK has a worse debt/assets ratio than last year.
SRBK Yearly Shares OutstandingSRBK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
SRBK Yearly Total Debt VS Total AssetsSRBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SRBK has an Altman-Z score of -0.53. This is a bad value and indicates that SRBK is not financially healthy and even has some risk of bankruptcy.
SRBK has a Altman-Z score of -0.53. This is amongst the best in the industry. SRBK outperforms 99.75% of its industry peers.
SRBK has a debt to FCF ratio of 131.19. This is a negative value and a sign of low solvency as SRBK would need 131.19 years to pay back of all of its debts.
SRBK has a worse Debt to FCF ratio (131.19) than 88.13% of its industry peers.
A Debt/Equity ratio of 4.44 is on the high side and indicates that SRBK has dependencies on debt financing.
SRBK has a worse Debt to Equity ratio (4.44) than 96.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.44
Debt/FCF 131.19
Altman-Z -0.53
ROIC/WACC0.37
WACC3.69%
SRBK Yearly LT Debt VS Equity VS FCFSRBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.08 indicates that SRBK may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.08, SRBK belongs to the top of the industry, outperforming 99.75% of the companies in the same industry.
A Quick Ratio of 0.08 indicates that SRBK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.08, SRBK belongs to the top of the industry, outperforming 99.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
SRBK Yearly Current Assets VS Current LiabilitesSRBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.05% over the past year.
SRBK shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.26%.
Measured over the past years, SRBK shows a very strong growth in Revenue. The Revenue has been growing by 40.27% on average per year.
EPS 1Y (TTM)99.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.57%
Revenue 1Y (TTM)22.26%
Revenue growth 3Y40.27%
Revenue growth 5YN/A
Sales Q2Q%-33.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SRBK Yearly Revenue VS EstimatesSRBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRBK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRBK Price Earnings VS Forward Price EarningsSRBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRBK indicates a rather cheap valuation: SRBK is cheaper than 99.24% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SRBK is valued a bit more expensive than the industry average as 71.72% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 19.55
EV/EBITDA 4.94
SRBK Per share dataSRBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

1

5. Dividend

5.1 Amount

SRBK has a Yearly Dividend Yield of 1.37%.
SRBK's Dividend Yield is slightly below the industry average, which is at 3.29.
Compared to an average S&P500 Dividend Yield of 2.34, SRBK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

SRBK does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SRBK Yearly Dividends per shareSRBK Yearly Dividends per shareYearly Dividends per share 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
SRBK Yearly Income VS Free CF VS DividendSRBK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M -2M -4M -6M -8M -10M

SR BANCORP INC

NASDAQ:SRBK (7/21/2025, 8:00:00 PM)

After market: 14.33 0 (0%)

14.33

+0.02 (+0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)N/A N/A
Inst Owners25.12%
Inst Owner Change0%
Ins Owners6.88%
Ins Owner Change35.83%
Market Cap128.97M
AnalystsN/A
Price TargetN/A
Short Float %6.88%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date06-30 2025-06-30 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.11
P/FCF 19.55
P/OCF 16.97
P/B 0.66
P/tB 0.77
EV/EBITDA 4.94
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.73
FCFY5.12%
OCF(TTM)0.84
OCFY5.89%
SpS4.61
BVpS21.67
TBVpS18.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.01%
ROE -0.05%
ROCE 7.23%
ROIC 1.37%
ROICexc 1.46%
ROICexgc 1.57%
OM 41.16%
PM (TTM) N/A
GM N/A
FCFM 15.9%
ROA(3y)-0.18%
ROA(5y)N/A
ROE(3y)-0.86%
ROE(5y)N/A
ROIC(3y)0.46%
ROIC(5y)N/A
ROICexc(3y)0.49%
ROICexc(5y)N/A
ROICexgc(3y)0.52%
ROICexgc(5y)N/A
ROCE(3y)2.55%
ROCE(5y)N/A
ROICexcg growth 3Y-15.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y-15.84%
ROICexc growth 5YN/A
OM growth 3Y-28.83%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 4.44
Debt/FCF 131.19
Debt/EBITDA 44.23
Cap/Depr 40.18%
Cap/Sales 2.41%
Interest Coverage 1.09
Cash Conversion 38.83%
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -0.53
F-Score6
WACC3.69%
ROIC/WACC0.37
Cap/Depr(3y)86.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.89%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.26%
Revenue growth 3Y40.27%
Revenue growth 5YN/A
Sales Q2Q%-33.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2301.97%
EBIT growth 3Y-0.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2456.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6232.5%
OCF growth 3YN/A
OCF growth 5YN/A